AG003AJW

77181-69-2 | 1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione

Chemical structure of 1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione, CAS 77181-69-2
AG003AJW
sdsSDS
sdsCOA
TIP This product is typically in stock.Please contact us for quotation.
Request For Quotation

CAS Number 77181-69-2
Catalog Number AG003AJW(AGN-PC-0UB740)
Chemical Name 1-β-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione
IUPAC Name 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione
InChI InChI=1S/C11H13BrN2O6/c12-2-1-5-3-14(11(19)13-9(5)18)10-8(17)7(16)6(4-15)20-10/h1-3,6-8,10,15-17H,4H2,(H,13,18,19)/b2-1+/t6-,7-,8+,10-/m1/s1
InChI Key GCQYYIHYQMVWLT-HQNLTJAPSA-N
MDL Number MFCD00866949
Molecular Formula C11H13BrN2O6
Molecular Weight 349.1347
SMILES [C@@H]1([C@@H](O)[C@H](O)[C@H](O1)CO)N1C(NC(C(=C1)C=CBr)=O)=O
UNII C7VOZ162LV
Synonyms
1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil, 5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil, brovavir, BV-ara-U, BV-araU, sorivudine, SORIVUDINE, Bravavir, Usevir, Brovavir, 77181-69-2, BVAU, BV-Ara-U, YN-72, Bromovinyluridine, 5-Bromovinyl-araU, BV-araU, Sorivudinum [INN-Latin], SQ-32756, Sorivudina [INN-Spanish], UNII-C7VOZ162LV, ARYS-01, CCRIS 5285, (E)-5-(2-Bromovinyl)uridine, DRU-0136, C7VOZ162LV, (E)-5-(2-Bromovinyl)-1-beta-D-arabinofuranosyluracil, CHEMBL70046, 1-beta-D-Arabinofuranosyl-(E)-5-(2-bromovinyl)uracil, (+)-1-beta-D-Arabinofuranosyl-5-((E)-2-bromovinyl)uracil, (E)-1-beta-D-Arabinofuranosyl-5-(2-bromoethenyl)-2,4(1H,3H)-pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromovinyl)uracil, Sorivudina, Sorivudinum, 2,4(1H,3H)-Pyrimidinedione, 1-beta-D-arabinofuranosyl-5-(2-bromoethenyl)-, (E)-, C11H13BrN2O6, Bromovinyl araU, BVaraU, Sorivudine [USAN:BAN:INN:JAN], Sorivudine [USAN:INN:BAN:JAN], Bravavir (TN), BV ara-U, AC1NQZN1, SCHEMBL82640, Sorivudine (JAN/USAN/INN), CHEBI:32152, 5-[(E)-2-bromoethenyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione, ZINC3653374, BDBM50206491, JA-001, AKOS025149268, DB11998, SB18958, SO-32756, LS-135099, SQ 32,756, D01734, 5-(2-bromovinyl)-1-beta-D-arabinofuranosyluracil, 1-.beta.-D-arabinofuranosyl-5-(2-bromovinyl)uracil, 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil, 2,4(1H,3H)-Pyrimidinedione, 1-.beta.-D-arabinofuranosyl-5-[(1E)-2-bromoethenyl]-, 5-((E)-2-Bromo-vinyl)-1-((2R,3S,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-4-hydroxy-1H-pyrimidin-2-one, 5-[(E)-2-bromovinyl]-1-[(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione, Usevir (TN), D03TGJ, C11-H13-Br-N2-O6, CID5282192, 1-beta-D-Arabinofuranosyl-5-[(1E)-2-bromoethenyl]-2,4(1H,3H)-pyrimidinedione,

Related Research Chemicals

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited